Secondary adrenal insufficiency secondary prevention

Jump to navigation Jump to search

Secondary adrenal insufficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adrenal insufficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Secondary adrenal insufficiency secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Secondary adrenal insufficiency secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Secondary adrenal insufficiency secondary prevention

CDC on Secondary adrenal insufficiency secondary prevention

Secondary adrenal insufficiency secondary prevention in the news

Blogs on Secondary adrenal insufficiency secondary prevention

Directions to Hospitals Treating Adrenal insufficiency

Risk calculators and risk factors for Secondary adrenal insufficiency secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There are no established measures for the secondary prevention of [disease name].

OR

Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].

Secondary Prevention

Effective measures for the secondary prevention of [disease name] include:

  • Patient and family members involved in patient care should be properly educated about risks of hormone replacement therapy.[1][2]
  • Patient should also be educated about dose adjustments during acute illnesses.[3][4]
  • Asymptomatic patients can also wear an identification bracelet stating the name of the disease to ensure proper emergency treatment during an adrenal crisis.[5]

References

  1. Tucci V, Sokari T (2014). "The clinical manifestations, diagnosis, and treatment of adrenal emergencies". Emerg. Med. Clin. North Am. 32 (2): 465–84. doi:10.1016/j.emc.2014.01.006. PMID 24766944.
  2. Napier C, Pearce SH (2014). "Current and emerging therapies for Addison's disease". Curr Opin Endocrinol Diabetes Obes. 21 (3): 147–53. doi:10.1097/MED.0000000000000067. PMID 24755997.
  3. Napier C, Pearce SH (2012). "Autoimmune Addison's disease". Presse Med. 41 (12 P 2): e626–35. doi:10.1016/j.lpm.2012.09.010. PMID 23177474.
  4. Quinkler M (2012). "[Addison's disease]". Med Klin Intensivmed Notfmed (in German). 107 (6): 454–9. doi:10.1007/s00063-012-0112-3. PMID 22907517.
  5. Hahner S, Allolio B (2005). "Management of adrenal insufficiency in different clinical settings". Expert Opin Pharmacother. 6 (14): 2407–17. doi:10.1517/14656566.6.14.2407. PMID 16259572.


Template:WikiDoc Sources